Medicare Enrolled

Dr. Philip Kramer, M.D.

Ophthalmology · Staten Island, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1460 VICTORY BLVD, Staten Island, NY 10301
7184470022
In practice since 2005 (20 years)
NPI: 1437150547 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kramer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kramer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kramer

Dr. Philip Kramer is an ophthalmology specialist in Staten Island, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kramer performed 14,720 Medicare services across 7,929 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kramer received a total of $1,094 from 17 pharmaceutical and/or device companies across 70 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kramer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in NY $1,094 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,720
Medicare services
Top 5% in NY for ophthalmology
7,929
Unique beneficiaries
$167
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~736 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
3,800 $109 $350
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,718 $35 $90
Retinal and optic nerve function test
A diagnostic test that measures how well the retina and optic nerve are functioning.
2,277 $120 $435
Aflibercept eye injection (Eylea) 1,344 $691 $1,125
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
808 $100 $651
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
624 $51 $125
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
514 $32 $90
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
490 $25 $65
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
262 $131 $400
Amniotic membrane placement on eye surface
This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing.
258 $1,285 $3,000
Complete ultrasound of brain blood flow
An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation.
207 $181 $400
Ultrasound of brain blood flow following medication
An ultrasound test used to assess blood flow within the brain after a medication has been administered.
207 $215 $400
Ultrasound of brain blood flow
An ultrasound test used to examine blood flow within the brain to check for blood clots.
207 $157 $400
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
146 $85 $300
Ultrasound scan to determine eye length and lens power
An ultrasound procedure used to measure the length of the eye and calculate the power of the lens.
119 $60 $197
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
118 $32 $100
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
114 $31 $90
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
89 $84 $300
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
83 $127 $570
Retinal laser destruction of growth
A laser procedure used to destroy abnormal growths in the retina.
73 $479 $1,515
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
64 $313 $2,000
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
58 $302 $1,000
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
57 $85 $302
Eyelash removal with forceps
This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area.
43 $13 $153
Incision and drainage of eyelid abscess
A minor surgical procedure to cut open and drain an infected, pus-filled swelling on the eyelid.
16 $266 $450
Removal of foreign body from external eye
This procedure involves the removal of a foreign object from the surface of the eye, specifically from the conjunctiva or sclera.
13 $25 $280
Removal of chronic eyelid growth
This procedure involves the surgical removal of a long-standing growth on the eyelid.
11 $118 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,094
Total received (2018-2024)
Avg $156/year across 7 years
Bottom 48% in NY for ophthalmology
17
Companies
70
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,094 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$202
2023
$472
2022
$272
2021
$56
2020
$19
2019
$50
2018
$22

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Tarsus Pharmaceuticals, Inc.
$75
Regeneron Healthcare Solutions, Inc.
$49
Bausch & Lomb Americas Inc.
$33
Mallinckrodt Hospital Products Inc.
$18
Dompe US, Inc.
$14
SUN PHARMACEUTICAL INDUSTRIES INC.
$13
Top 3 companies account for 77.4% of 2024 payments
All-time payments by company (2018-2024) ›
Sun Pharmaceutical Industries Inc.
$388
ABBVIE INC.
$155
Regeneron Healthcare Solutions, Inc.
$117
Bausch & Lomb Americas Inc.
$101
Tarsus Pharmaceuticals, Inc.
$75
SUN PHARMACEUTICAL INDUSTRIES INC.
$40
Bausch & Lomb, a division of Bausch Health US, LLC
$27
Alcon Vision LLC
$25
Shire North American Group Inc
$22
Integra LifeSciences Corporation
$22
Horizon Therapeutics plc
$22
Carl Zeiss Meditec AG
$19
Apellis Pharmaceuticals, Inc.
$18
Mallinckrodt Hospital Products Inc.
$18
Oyster Point Pharma, Inc.
$16
Aerie Pharmaceuticals, Inc.
$15
Dompe US, Inc.
$14
Top 3 companies account for 60.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · BILAYER WOUND MATRIX (BWM) · Cequa · DURYSTA · EYLEA · EYLEA HD · LUMIGAN · MIEBO · None Specified · OXERVATE · Syfovre · TEPEZZA · TYRVAYA · VUITY · VYZULTA · XDEMVY · XIIDRA · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Staten Island?
Compare ophthalmologists in the Staten Island area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
1,321
Per 100K population
268.1
County median income
$98,290
Nearest hospital
RICHMOND UNIVERSITY MEDICAL CENTER
1.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kramer is a clinical cardiology specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kramer experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kramer performed 3,800 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kramer receive payments from pharmaceutical companies?
Yes. Dr. Kramer received a total of $1,094 from 17 companies across 70 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kramer's costs compare to other ophthalmologists in Staten Island?
Dr. Kramer's average Medicare payment per service is $167. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kramer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →